Company Filing History:
Years Active: 2001
Title: Solomon Habtemariam: Innovator in Pharmaceutical Applications
Introduction
Solomon Habtemariam is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of skin diseases. His innovative work focuses on the use of stereoisomers of calendula glycosides for therapeutic purposes.
Latest Patents
Habtemariam holds a patent for the "Use of stereoisomers of calendula glycosides for the treatment of psoriasis." This patent details the application of stereoisomeric glycosidic compounds as pharmaceutical agents against psoriasis. The compounds are formulated to target diseases involving hyperproliferation of dermis cells, showcasing his commitment to advancing medical treatments.
Career Highlights
He is affiliated with the University of Strathclyde, where he continues to engage in research and development. His work has garnered attention for its potential impact on dermatological therapies. With 1 patent to his name, Habtemariam exemplifies the spirit of innovation in the pharmaceutical industry.
Collaborations
Throughout his career, Habtemariam has collaborated with esteemed colleagues such as William Howard Stimson and Alexander Irvine Gray. These partnerships have enriched his research and contributed to the advancement of his projects.
Conclusion
Solomon Habtemariam stands out as an inventor dedicated to improving healthcare through innovative pharmaceutical solutions. His work in the treatment of psoriasis highlights the importance of research and development in addressing medical challenges.